Adverum生物技术 ADVM 深 沪
已收盘 12-09 16:00:00 美东时间
4.36
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 4.36
- 总市值 9.15万
- 52周最高 5.75
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.78
- 委 比 0.00%
- 总股本 2.10万
- 历史最高 624.80
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.78
- 每 手 1
- 风险率 0.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Annexon Appoints Renowned Retinal Surgeon and Biotechnology Entrepreneur Mark S. Blumenkranz, M.D., M.M.S. to its Board of Directors
<p>Annexon, Inc. announced the appointment of Mark S. Blumenkranz, M.D., M.M.S., to its board of directors, bringing over four decades of expertise in retinal disease. The company also announced the departure of Muneer Satter after 11 years of service. Dr. Blumenkranz, a renowned retinal surgeon and entrepreneur, will contribute to advancing Annexon's late-stage clinical programs, particularly vonaprument for geographic atrophy. The company highl...
08-10 20:05
Eli Lilly And Adverum Announce Expiration Of Tender Offer By Lilly Subsidiary To Acquire All Outstanding Adverum Shares For $3.56 Cash Plus Up To $8.91 Per Share In Contingent Value Rights, As Scheduled On December 8
Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM) today announced that the tender offer (the "Offer") by Flying Tigers Acquisition Corporation ("Purchaser"), a direct wholly-owned
2025-12-09 21:33
Adverum Urges Shareholders to Accept Eli Lilly Buyout Offering Up to $12.47 Per Share
Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy as a potential One And DoneTM treatment to preserve sight for life, today announced that it has
2025-12-01 20:26
Adverum Biotechnologies Faces Lease Termination Notice
An announcement from Adverum Biotechnologies ( ($ADVM) ) is now available. On N...
2025-11-22 05:41
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
2025-11-18 15:28
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholder...
2025-11-11 06:30
Weekly Recap: 13 Health Press Releases You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including new healthcare acquisitions, Halloween safety tips, and the adoption of AI in affordable heal...
2025-10-31 18:22
